Treatment responsive executive and behavioral dysfunction associated with Vitamin B12 deficiency

Neurocase

Volumn 14, Issue 2, 2008, Pages 147-150

  Akdal, Gülden ^a   Yener, Görsev G ^a   Kurt, Pinar ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Behavioral disturbance; Frontal lobe dysfunction; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; RISPERIDONE;

ADULT; ARTICLE; ATAXIA; BEHAVIOR DISORDER; BRAIN DYSFUNCTION; CASE REPORT; CLINICAL FEATURE; CYANOCOBALAMIN DEFICIENCY; DELUSION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG RESPONSE; EMOTIONAL DISORDER; HUMAN; INSOMNIA; MALE; MANIA; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PERSONALITY DISORDER; SENSORY DYSFUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT DURATION; VIBRATION SENSE; VITAMIN BLOOD LEVEL;

AFFECTIVE SYMPTOMS; BEHAVIORAL SYMPTOMS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERSONALITY DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 47149115765     PISSN: 13554794     EISSN: 14653656     Source Type: Journal    
DOI: 10.1080/13554790802032242     Document Type: Article

References (13)

1. Akdal, G., Yener, G. G., Ada, E. and Halmagyi, G. M. (2007) Eye movement disorders in vitamin B12 deficiency: Two new cases and a review of the literature. European Journal of Neurology, 14, pp. 1170-1172.
2. Boxer, A. L., Kramer, J. H., Johnston, K., Goldman, J., Finley, R. and Miller, B. L. (2005) Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. Neurology, 64, pp. 1431-1434.
3. Garcia, A., Haron, Y., Pulman, K., Hua, L. and Freedman, M. (2004) Increases in homocysteine are related to worsening of Stroop scores in healthy elderly persons: A prospective follow-up study. Journal of Gerontology: A Biological Science and Medical Science, 59:12, pp. 1323-1327.
4. Healton, E. B., Savage, D. G., Brust, J. C., Garrett, T. J. and Lindenbaum, J. (1991) Neurologic aspects of cobalamin deficiency. Medicine (Baltimore), 70, pp. 229-245.
5. Herrmann, W., Herrmann, M. and Obeid, R. (2007) Hyperhomocysteinaemia: A critical review of old and new aspects. Current Drug Metabolism, 8:1, pp. 17-31.
6. Holmes, J. M. (1956) Cerebral manifestations of vitamin B12 deficiency. British Medical Journal, 2, pp. 1394-1398.
7. Krauthammer, C. and Klerman, G. L. (1978) Secondary mania: Manic syndromes associated with antecedent physical illness or drugs. Archives in General Psychiatry, 35, pp. 1333-1339.
8. Lund and Manchester Groups (1994) Consensus statement: Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology and Neurosurgery Psychiatry, 57, pp. 416-418.
9. Obeid, R. and Herrmann, W. (2006) Mechanisms of homocyteine neurotoxicity in neurodegenerative diseases with special reference to dementia. Federation of European Biomedical Societies, 580, pp. 2994-3005.
10. Riggs, K. M., Spiro 3rd, A., Tucker, K. and Rush, D. (1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition, 63, pp. 306-314.
11. Schreinzer, D., Barnas, C. and Fischer, P. (2003) Frontotemporal dementia associated with vitamin B12 deficiency. Journal of American Geriatric Society, 51, pp. 280-281.
12. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H. D'Agostino, R. B. et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 346, pp. 476-483.
13. Wolters, M., Strohle, A. and Hahn, A. (2004) Cobalamin: A critical vitamin in the elderly. Preventive Medicine, 3, pp. 1256-1266.